
ctDNA-Guided Therapy May Improve Breast Cancer Outcomes
For patients with metastatic hormone receptor (HR)-positive, HER2-negative breast cancer, there were various trials to have come out of the 2025 ASCO Annual Meeting that are worth keeping your eye on, Dr. Julia E. McGuinness said in an interview with Dr. …